Bill Doyle is Managing Partner of venture capital investor WFD Ventures LLC and a member of the Investment Team of Pershing Square Capital, L.P. Previously, Bill was an executive of Johnson & Johnson where he served as a member of Johnson & Johnson’s Consumer Pharmaceuticals and Medical Devices Group Operating Committee and Vice President, Licensing and Acquisitions. At J&J, Bill was also Chairman of the Medical Devices Research and Development Council, Worldwide President of Biosense-Webster and a member of the boards of directors of Cordis and Johnson & Johnson Development Corporation. Earlier in his career Bill was a consultant with McKinsey & Company. Bill holds an S.B. in materials science and engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School.
Bill Doyle
Chairman, NovoCure
